Autopsy report · NCT01722890

CharactHer. ICORG 12-09, V3

“As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 8 years 6 months before it stopped.
• 130 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Cancer Trials Ireland

Sponsor type

University, hospital or other

Conditions

HER2-positive Breast Cancer; TNM Stage II-IV Breast Cancer

Participants

130

Sites

2

Countries

Ireland, Italy

Trials that died the same way

• Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
  “The study team decided to not move forward with enrolling patients because funding was not identified to support the project.” (63% match in meaning)
• Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
  “The sponsor decided to terminate the study due to financial issues following an FDA request for a partial clinical hold.” (62% match in meaning)
• Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
  “Study closed due to funding, 0 patient accrual.” (62% match in meaning)
• Consolidation Therapy in Patients With Metastatic Solid Malignancies
  “Sponsor decision to discontinue study.” (62% match in meaning)
• Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers
  “Sponsor decision to terminate the study” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.